Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | BLTE | PTGX | ||
| Company | Arcellx Inc | Belite Bio Inc ADR | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 114.89 | 171.04 | 105.96 | ||
| High | 115.08 | 171.20 | 106.66 | ||
| Low | 114.87 | 167.00 | 103.02 | ||
| Latest | 115.07 | 168.65 | 104.32 | ||
| Change | +0.18 | -3.28 | -0.40 | ||
| % Change | +0.16% | -1.91% | -0.38% | ||
| Volume | 398,707 | 34,736 | 281,013 | ||
| 20-Day Average Volume | 1,184,261 | 160,920 | 952,701 | ||
| Previous Close | 114.89 | 171.93 | 104.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 114.72 | 163.32 | 101.66 | ||
| 20-Day Raw Stochastic | 93.92% | 59.01% | 80.91% | ||
| 20-Day Relative Strength | 78.50 | 50.65 | 58.67 | ||
| Weighted Alpha | +22.28 | +190.84 | +102.93 | ||
| Today's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 04/08/26 | -5.73% since 04/08/26 | +2.40% since 04/08/26 | ||
| Low | 114.77 on 04/10/26 | 167.00 on 04/15/26 | 95.40 on 04/13/26 | ||
| High | 115.04 on 04/15/26 | 183.67 on 04/09/26 | 106.66 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +0.53% since 03/13/26 | +2.66% since 03/13/26 | +13.19% since 03/13/26 | ||
| Low | 114.30 on 03/19/26 | 146.61 on 03/24/26 | 90.58 on 03/18/26 | ||
| High | 115.04 on 04/15/26 | 183.67 on 04/09/26 | 107.84 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +68.32% since 01/15/26 | +12.61% since 01/15/26 | +23.36% since 01/15/26 | ||
| Low | 63.15 on 02/20/26 | 146.61 on 03/24/26 | 77.00 on 02/23/26 | ||
| High | 115.04 on 04/15/26 | 200.00 on 02/03/26 | 107.84 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +24.49% since 10/15/25 | +107.33% since 10/15/25 | +34.58% since 10/15/25 | ||
| Low | 60.35 on 01/05/26 | 81.01 on 10/16/25 | 73.08 on 10/23/25 | ||
| High | 115.04 on 04/15/26 | 200.00 on 02/03/26 | 107.84 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,718,766 | 6,871,182 | 6,682,078 | ||
| Shares Outstanding, K | 58,480 | 39,965 | 63,809 | ||
| Annual Sales | 22,290,000 | 0 | 46,020,000 | ||
| Annual Net Income | -228,930,000 | -77,610,000 | -130,150,000 | ||
| Last Quarter Sales | 1,650,000 | 0 | 7,440,000 | ||
| Last Quarter Net Income | -58,110,000 | -25,320,000 | -44,380,000 | ||
| 60-Month Beta | 0.25 | -1.22 | 2.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 02/26/26 | -0.38 on 03/02/26 | -0.69 on 02/25/26 | ||
| Latest Earnings Date | 05/14/26 | 05/12/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||